Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2007 Sep;78(9):970-4.
doi: 10.1136/jnnp.2006.107243. Epub 2007 Mar 2.

Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis

A Fleury  1 , M Hernández, M Avila, G Cárdenas, R J Bobes, M Huerta, G Fragoso, L Uribe-Campero, L J S Harrison, R M E Parkhouse, E Sciutto
Affiliations
Controlled Clinical Trial

Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis

A Fleury et al. J Neurol Neurosurg Psychiatry. 2007 Sep.

Abstract

Introduction: Neurocysticercosis (NC), a parasitic disease caused by Taenia solium, may be either asymptomatic or show a mild to severe clinical picture with intracranial hypertension. The most severe form of the disease is caused when viable cysticerci are localised in the ventricles or in subarachnoidal cisterns at the base of the skull. Detection of the secreted metacestode antigen HP10 in cerebrospinal fluid is a sensitive and specific method for the diagnosis of these severe NC cases.

Objective and methods: To evaluate the validity of HP10 antigen detection ELISA when applied to serum, using paired serum and cerebrospinal fluid samples from 116 radiologically and clinically characterised NC patients.

Results: The HP10 antigen assay exhibited a similarly high sensitivity in identifying severe NC cases from sera (84.8%) and CSF (91.3%). In contrast, HP10 antigen was rarely detected in asymptomatic or mild NC cases (3 of 57). Importantly, the HP10 antigen assay applied to serum showed high specificity (94%) when used in 126 serum samples of non-NC subjects from an endemic community with a confirmed coproparasitological diagnosis of intestinal parasitic infections. Finally, the HP10 assay also proved to be of value in the follow-up of treated patients.

Conclusion: This study confirms that detection of the metacestode HP10 antigen in serum is a useful tool for diagnosis and follow-up of patients with severe forms of NC treated with cysticidal drugs.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

Comment in

References

    1. Sanchez A L, Ljungstrom I, Medina M T. Diagnosis of human neurocysticercosis in endemic countries: a clinical study in Honduras. Parasitol Int 1999181–89. - PubMed
    1. Fleury A, Gomez T, Alvarez I.et al High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiology 200322139–145. - PubMed
    1. Fleury A, Morales J, Bobes R J.et al An epidemiological study of familial neurocysticercosis in an endemic Mexican community. Trans R Soc Trop Med Hyg 2006100551–558. - PubMed
    1. Fleury A, Dessein A, Preux P M.et al Symptomatic human neurocysticercosis: age, sex and exposure factors relating with disease heterogeneity. J Neurol 2004251830–837. - PubMed
    1. Gongora‐Rivera F, Soto‐Hernandez J L, Gonzalez Esquivel D.et al Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis. Neurology 200666436–438. - PubMed

Publication types

MeSH terms